Industry Reports
Amylin Pharmaceuticals Reports Second Quarter Results total revenue of $164.4 for the quarter ended June 30, 2010
Amylin Pharmaceuticals, Inc. reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.